BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 699976)

  • 1. Clozapine concentrations in brain regions: relationship to dopamine metabolite increase.
    Wilk S; Stanley M
    Eur J Pharmacol; 1978 Sep; 51(2):101-7. PubMed ID: 699976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine metabolism in the nucleus accumbens: the effect of clozapine.
    Wilk S; Glick SD
    Eur J Pharmacol; 1976 May; 37(1):203-6. PubMed ID: 1278242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential sensitivity of two dopaminergic structures in rat brain to haloperidol and to clozapine.
    Wilk S; Watson E; Stanley ME
    J Pharmacol Exp Ther; 1975 Nov; 195(2):265-70. PubMed ID: 1185596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of antipsychotic drugs and their clinically inactive analogs on dopamine metabolism.
    Stanley M; Wilk S
    Eur J Pharmacol; 1977 Aug; 44(4):293-302. PubMed ID: 19267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in dopamine release and metabolism in rat striatal subregions following acute clozapine using in vivo microdialysis.
    O'Connor WT; Drew KL; Ungerstedt U
    Neurosci Lett; 1989 Mar; 98(2):211-6. PubMed ID: 2710415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perlapine and dopamine metabolism: prediction of antipsychotic efficacy.
    Wilk S; Stanley M
    Eur J Pharmacol; 1977 Jan; 41(1):65-72. PubMed ID: 12986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-related effects of clozapine and risperidone on the pattern of brain regional serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
    Batool F; Hasnat A; Haleem MA; Haleem DJ
    Acta Pharm; 2010 Jun; 60(2):129-40. PubMed ID: 21134850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats.
    Invernizzi R; Morali F; Pozzi L; Samanin R
    Br J Pharmacol; 1990 Aug; 100(4):774-8. PubMed ID: 2207499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The differential effects of morphine, oxotremorine and antipsychotic drugs on DOPAC concentrations in rat brain.
    Stanley M; Wilk S
    J Pharm Pharmacol; 1980 Aug; 32(8):567-70. PubMed ID: 6106695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine metabolism in the tuberculum olfactorium.
    Wilk S; Watson E; Glick SD
    Eur J Pharmacol; 1975 Jan; 30(1):117-20. PubMed ID: 1122932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of amfonelic acid on the haloperidol- and clozapine-induced increase in extracellular DOPAC in the nucleus accumbens and the striatum.
    Rivest R; Marsden CA
    Synapse; 1992 Jan; 10(1):71-8. PubMed ID: 1371367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic antagonists attenuate the increase in accumbens and striatum dopamine metabolism produced by clozapine but not by haloperidol.
    Rivest R; Marsden CA
    Br J Pharmacol; 1991 Sep; 104(1):234-8. PubMed ID: 1786513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine: reduction of the initial dopamine turnover increase by repeated treatment.
    Waldmeier PC; MaƮtre L
    Eur J Pharmacol; 1976 Jul; 38(1):197-203. PubMed ID: 954831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased release of dopamine in vivo by BMY-14802: contrasting pattern to clozapine.
    Rao TS; Cler JA; Oei EJ; Iyengar S; Wood PL
    Neuropharmacology; 1990 May; 29(5):503-6. PubMed ID: 1972552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
    Meltzer HY; Chai BL; Thompson PA; Yamamoto BK
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1452-61. PubMed ID: 8138957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-dopa esters as potential prodrugs: effect on brain concentration of dopamine metabolites in reserpinized mice.
    Cooper DR; Marrel C; van de Waterbeemd H; Testa B; Jenner P; Marsden CD
    J Pharm Pharmacol; 1987 Oct; 39(10):809-18. PubMed ID: 2891818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated atypical neuroleptic administration: effects on central dopamine metabolism monitored by in vivo voltammetry.
    Maidment NT; Marsden CA
    Eur J Pharmacol; 1987 Apr; 136(2):141-9. PubMed ID: 3595718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies on the effects of chronic clozapine on regional extracellular dopamine levels in the brain of conscious rats.
    Invernizzi R; Pozzi L; Samanin R
    Brain Res; 1995 Jan; 670(1):165-8. PubMed ID: 7719718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of haloperidol and low dose clozapine on the acetylcholine turnover rate in rat forebrain structures.
    Bluth R; Langnickel R
    Biomed Biochim Acta; 1985; 44(10):1531-9. PubMed ID: 4084256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of haloperidol, Clozapine, and methadone on rat striatal cholinergic and dopaminergic dynamics.
    Ladinsky H; Consolo S; Samanin R; Algeri S; Ponzio F
    Adv Biochem Psychopharmacol; 1980; 24():259-65. PubMed ID: 7405665
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.